As a telehealth patient-management platform headquartered at 285 North El Camino Real in Encinitas, Enhance.MD connects patients with licensed providers who prescribe compounded semaglutide and tirzepatide for medical weight management. The subscription model requires a comprehensive blood panel and virtual provider consultation before any GLP-1 medication is prescribed, a lab-first intake that aligns with the evidence-based nutritional counseling at Nurture & Flow Nutrition. Enhance.MD operates as the administrative platform supporting Enhance Wellness PC and iThriveMD PC, whose physicians and nurse practitioners deliver care exclusively through a telehealth interface. Compounded medications ship directly from partner pharmacies to the patient's address, bypassing the in-clinic dispensing model used by IV-therapy providers such as Hydration Room on the same El Camino Real corridor. Tirzepatide's dual GLP-1 and GIP receptor activation targets both gastric emptying rate and incretin-driven insulin secretion, producing a broader metabolic response than single-pathway semaglutide monotherapy.